Home
About Us
Company Profile
History
Contact Us
News
Company News
Products
Randox
Kikkoman
Biomex
Scantibodies
Diagnostic materials
Proliant
Access
Animal serum
Biorad
Solution
CXO Customized Service Solution
Core Raw Materials for Diagnostics
Quality Control Product Solutions
Service Center
Download
中文
English
Realbio and Thermo Fisher have entered into a strategic partnership to co-build a new ecosystem for localized IVD quality control services.
2026-05-12
On May 12, the strategic signing ceremony between Realbio and Thermo Fisher Scientific, a global leader in scientific services, was successfully held at the Thermo Fisher Customer Experience Center in Shanghai. The two parties will engage in in-depth collaboration on "integrated solutions for in-vitro diagnostic quality control materials," jointly embarking on a new chapter of resource sharing and value co-creation. Attendees at the signing ceremony included Patrick Jones, Global President of Professional Diagnostics at Thermo Fisher; Anuj Dhingra, Global Vice President of Professional Diagnostics; Linda Tang, Commercial Director of Professional Diagnostics, China; Luca Saronni, Global Chief Business Development Manager of Clinical Diagnostics; Liangchao Huang, Senior Sales Manager of Clinical Diagnostics, China; Anita Zhang, Product Specialist of Clinical Diagnostics Marketing, China; as well as Su Shaobo, Chairman of Shenzhen Realbio Group; Jiang Wenyu, Deputy General Manager of Operations; and Ji Hongyu, International Business Development Manager. This signing represents not only a joining of hands between the two enterprises but also another significant milestone for Ruiyali in enhancing its local industrial translation capabilities.
Guangdong Provincial Engineering Technology Research Center for IVD Core Raw Materials (Realbio) Inauguration & Cooperation Signing Ceremony between Shenzhen Realbio Group and Shenzhen CDC
2026-04-10
On April 9, Realbio Group and the Shenzhen CDC officially signed a strategic cooperation agreement in Shenzhen. The two parties will engage in in-depth collaboration on the construction of a clinical translation evaluation system for in-vitro diagnostics (IVD), with the aim of bridging the "last mile" from the laboratory to clinical application, enhancing the industry's regulatory market access capabilities, and contributing to the development of a public service platform for the diagnostics field in the Greater Bay Area.
Realbio Debuts at the 23rd CACLP: Integrated CRO Central Lab Model Accelerates IVD Registration
2026-03-23
On March 21, 2026, the 23rd China Association of Clinical Laboratory Practice Expo (CACLP) — the annual bellwether of the IVD industry — grandly opened at the Xiamen International Expo Center. As an enterprise specializing in upstream core raw materials and integrated services for IVD, Realbio made a striking debut with its "CRO New Model for the Full Lifecycle of IVD Registration," demonstrating how, driven by global resource integration and local translation capabilities, it empowers partners to achieve compliant growth, cost reduction, and efficiency gains.
MEDICA Spotlight: How Realbio Paves Your "Fast Track" into China's IVD Market!
2025-11-20
From November 17 to 20, 2025, MEDICA — the world's premier B2B medical trade fair — was grandly held in Düsseldorf, Germany, bringing together over 5,000 exhibitors from 72 countries and more than 80,000 professional visitors from 165 nations. The event showcased cutting-edge advances in laboratory technology, diagnostics, and medical imaging. As a leader in upstream core raw materials and market services for IVD, Realbio presented its distinctive dual-engine model of "Core Raw Materials + Market Acceleration" at the exhibition, generating widespread interest and in-depth discussions among global industry experts, distributors, and investors across the laboratory technology and diagnostic equipment zones.
【Joining Forces, Opening a New Chapter】 Mindray-Realbio TGA Joint Lab Strategic Signing — A Triumph!
2025-11-06
On a sun-drenched day in Shenzhen, against the spirited backdrop of China's National Games in full swing, Mindray and Realbio held the grand strategic signing ceremony for their TGA Joint Laboratory — and it was a resounding success! A powerhouse alliance, a new journey unveiled.
EntropyLab Signs Strategic Expert Huang Boxing to Empower the IVD Industry
2025-08-15
To accelerate its strategic upgrade, strengthen its core competitiveness, and seize future development opportunities, Shenzhen Realbio Group recently announced a significant personnel appointment: Mr. Huang Boxing, a veteran leader in the in-vitro diagnostics field and former President of Roche Greater China, has been appointed as Strategic Advisor to the Group. Mr. Su Shaobo, Chairman of the Group, and Mr. Huang Boxing attended the appointment ceremony together.
HIV Laboratory Approved | Unlocking a Critical Service Qualification, Expanding the Service Scope of Our IVD Core Raw Material Service Platform
2025-08-06
Realbio has achieved a critical breakthrough in its service capability development: the HIV screening laboratory applied for by the company has successfully passed expert inspection and received official approval from the Shenzhen Municipal Health Commission. This is not merely a certificate of qualification — it represents a major leap forward in the capability building of the company's core service segment, injecting powerful momentum into serving the international market and empowering the IVD industry.
Realbio Shines at ADLM: A Global Diagnostics Ecosystem Leader Empowering IVD Industry Innovation and Upgrading
2025-08-05
From July 29 to 31, 2025, ADLM 2025 — the largest annual gathering in the global IVD field — was successfully held at the McCormick Place Convention Center in Chicago, USA. This year's expo brought together 1,020 exhibiting companies (including over 900 leading global IVD enterprises) and more than 25,000 professionals, focusing on diagnostic technology, laboratory science, and medical innovation, cementing its status as a landmark event in the global clinical laboratory field. At the expo, Realbio showcased to global IVD enterprises its full-value-chain service capabilities spanning R&D, manufacturing, and compliance. Through its three core business matrices, Realbio is accelerating the building of a globalized ecosystem for the diagnostics industry.
Randox and Realbio jointly launched OEM quality control raw materials to escort the localization of enterprise quality control.
2025-06-23
On May 26, the "Laboratory Quality Management Series Lecture - Shenzhen Station," jointly hosted by Realbio Group and Randox, concluded successfully in Pingshan Comprehensive Bonded Zone, Shenzhen. The conference brought together industry experts, business elites, and colleagues to explore technological innovations in quality control and industrial upgrading paths.